Physician profile
John C Lantis
NPI 1689663759
$922,411.54
in general payments reported to CMS, 2019-2025
42 companies · $280K in 2025
The $280K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $94K · 2020: $47K · 2021: $33K · 2022: $112K · 2023: $85K · 2024: $272K · 2025: $280K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $345K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $133K · Travel and Lodging: $98K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $46K · Honoraria: $7,400 · Food and Beverage: $4,890 · Education: $2,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $344,744.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $133,043.75 |
| Travel and Lodging | $98,293.36 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $45,750.00 |
| Honoraria | $7,400.00 |
| Food and Beverage | $4,889.51 |
| Education | $2,428.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $359,232.63 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $218,739.79 | 2019-2025 | Collagenase Santyl, Grafix, Versajet |
| Integra Lifesciences Corporation | $205,346.58 | 2019-2025 | Integra, Cytal, Primatrix |
| Solventum Corporation | $30,868.73 | 2024-2025 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
| Kci USA, INC. | $19,256.32 | 2019-2023 | Activ.A.C., Prevena, V.A.C. Veraflo |
| Organogenesis INC. | $18,786.04 | 2021-2025 | Via Matrix, Puraply |
| Ets Wound Care LLC | $12,414.46 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Molnlycke Health Care US, LLC | $10,856.16 | 2022 | |
| Polynovo North America LLC | $7,925.57 | 2024-2025 | Novosorb Btm |
| Imbed Biosciences INC. | $6,887.68 | 2022 | |
| Biodynamik, INC | $5,850.00 | 2024 | |
| Urgo Medical North America, LLC | $5,521.95 | 2019-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Avita Medical Americas, LLC | $4,400.00 | 2023 | Recell |
| Royal Biologics, INC. | $3,660.96 | 2021 | |
| Reddress USA, INC. | $3,300.00 | 2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medela Ag | $2,000.00 | 2022 | |
| Sanara Medtech INC. | $2,000.00 | 2022 | |
| Tei Medical INC. | $1,925.00 | 2019 | |
| Cook Medical LLC | $553.93 | 2019-2020 | |
| Convatec INC. | $550.00 | 2020 | |
| Biotissue Holdings INC. | $516.87 | 2019-2023 | |
| Orpyx Medical Technologies INC. | $400.00 | 2021 | |
| Cvrx, INC. | $308.51 | 2021-2022 | |
| Medtronic Vascular, INC. | $163.57 | 2019 | |
| Medela LLC | $157.14 | 2022 | |
| Boston Scientific Corporation | $130.33 | 2025 | Enroute Transcarotid Neuroprotection System |
| Musculoskeletal Transplant Foundation INC. | $127.41 | 2019-2023 | |
| Progenacare Global, LLC | $120.17 | 2023 | |
| Bolton Medical INC | $108.70 | 2020 | |
| Shockwave Medical, INC | $84.27 | 2020-2025 | |
| Tactile Systems Technology INC | $71.50 | 2025 | Nimbl, Flexitouch Plus |
| Leo Pharma INC. | $33.16 | 2025 | Spevigo |
| Acell, INC. | $24.01 | 2019 | |
| Advanced Oxygen Therapy INC. | $22.23 | 2025 | Topical Oxygen Chamber For Extremities |
| Mimedx Group, INC. | $17.02 | 2025 | |
| Bone Support INC. | $16.51 | 2024 | Ceramentbone Void Filler, Cerament G |
| Lemaitre Vascular, INC. | $13.28 | 2019 | |
| Misonix INC | $13.01 | 2021 | |
| Polarityte, INC. | $8.05 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$8,200.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lantis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.